2m 2m 2m 2m 2m 2m 2m
IMMUNOCORE SP ADS (IMCR)
NASDAQ
$29.85+$0.50 (+1.70%)
Price as of Jun 23, 2026 7:21 PM EDT- $1.5BMarket Cap
- -5.69%1-Year Change
- BiotechnologyIndustry
IMMUNOCORE SP ADS (IMCR)
$29.85+$0.50 (+1.70%)
IMCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.35 | ||
Change | +$0.75 (+2.62%) | ||
Open | $28.70 | ||
High | $29.63 | ||
Low | $28.25 | ||
Previous Close | $28.60 | ||
Volume | 893,060 | ||
30-Day Average Volume | 501,708 | ||
1-Week Change | 2.51% | ||
1-Month Change | 1.80% | ||
1-Year Change | -5.69% | ||
3-Year Change | -50.58% | ||
5-Year Change | -21.71% | ||
Fundamentals | |||
Shares Outstanding | 50.9M | ||
Total Assets | $1.1B | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $106.7M | ||
Net Income | $13.0M | ||
Free Cash Flow | -$15.6M | ||
EBIT | $16.3M | ||
EBITDA | $17.3M | ||
Net Working Capital | $763.7M | ||
EPS | $0.25 | ||
Enterprise Value/EBITDA | 83 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 4 | ||
P/E | 117 | ||
PEG | 1 | ||
Price/Free Cash Flow | -96 | ||
Price/Operating Cash Flow | -108 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue